Frustrated with the one size fits all approach to your diabetes?
What Makes Us Different
We hyper-personalize your care by bringing all elements of the diabetes ecosystem together, including medical devices, education, wearables, and therapeutics for you.
Our model of care is continuous. Our team is by your side 24/7 to help you understand your body, keep up with your care plan, or get you back on track. We look at trends to intervene earlier and provide better predictions about what your care plan should look like based on your data.
You no longer have to wait and see your physician physically for changes in your therapeutic plan. You now have the world’s best diabetes clinic in your pocket.
Remaining Engaged & Collecting Data
We Do This By
Remaining Engaged & Collecting Data
%
POINT | Average Reduction in HbA1C
More Care Team Engagement
More Patient Engagement on Educational Content
More Weight/BMI Data Points & Blood Pressure Data Points Analyzed (*Hypertensive Patients)
Data Received on Sleep Cycle, Movement Analysis, Daily Calorie Burn, Heart & Respiration Rate, Skin Temperature
Annual Glucose Data Points Analyzed when using CGM
Annual Glucose Data Points Analyzed when using BGM

Artificial Intelligence Assisted Healthcare
GluCare is one of the world’s first providers to embed the use of Artificial intelligence assisting us in everything that we do. Throughout the facility, we use AI to assist our physicians in providing an immediate and better diagnosis of conditions we manage. Here are some examples of the way we use AI:
AI-Assisted Retinal Screening
GluCare has introduced the region’s first use of artificial intelligence (AI) in retinal screenings. Diabetic retinopathy is a leading cause of blindness in working-age adults – affecting one-third of people with diabetes. Despite this fact, retinal screening is still not offered in many diabetes centers and less than half of diabetic patients undergo regular retinal screenings.
Our AI platform allows for instantaneous screening of diabetic retinopathy and age-related macular degeneration without the need to be referred elsewhere.
AI-Assisted Thyroid Screening Using Ultrasound
At GluCare, we are the first provider to use Artificial intelligence (AI) diagnosis to evaluate the sonographic calcifications of thyroid nodules.
Our approach of using both an endocrinologist and AI is a more sensitive and more objective method than simply relying on conventional methods (physicians alone) in the diagnosis of thyroid malignancies containing microcalcifications.